Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ AST SpaceMobile Prices Repurchase of Convertible Notes and Registered Direct Offering of Class A Common... (Business Wire) +++ AST SPACEMOBILE Aktie -3,48%

CONVATEC ADR Aktie

>CONVATEC ADR Performance
1 Woche: 0%
1 Monat: +4,6%
3 Monate: +12,4%
6 Monate: +27,1%
1 Jahr: +18,3%
laufendes Jahr: +28,3%
>CONVATEC ADR Aktie
Name:  CONVATEC GRP UNSP.ADR /4
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US21244X1090 / A2PWTA
Symbol/ Ticker:  2CVU (Frankfurt)
Kürzel:  FRA:2CVU, ETR:2CVU, 2CVU:GR
Index:  -
Webseite:  https://www.convatecgroup..
Marktkapitalisierung:  7070 Mio. EUR
Umsatz:  1976.39 Mio. EUR
EBITDA:  455.6 Mio. EUR
Gewinn je Aktie:  0.276 EUR
Schulden:  1035.66 Mio. EUR
Liquide Mittel:  56.18 Mio. EUR
Umsatz-/ Gewinnwachstum:  8.2% / 50%
KGV/ KGV lG:  42.12 / 21.23
KUV/ KBV/ PEG:  3.52 / 4.74 / 1.88
Gewinnm./ Eigenkapitalr.:  8.32% / 11.27%
Dividende je Aktie:  0.053 EUR
Dividendenrendite/ -schätzung:  0.4% / 1.77%
Div. Historie:  23.08.24 - 0.05259€
25.04.24 - 0.13386€
Insiderhandel:  -
Suchwörter:  CONVATEC ADR, CONVATEC
Letzte Datenerhebung:  25.06.25
>CONVATEC ADR Eigentümer
Aktien: 511.09 Mio. St.
f.h. Aktien: 1620 Mio. St.
Insider Eigner: -
Instit. Eigner: -
Leerverk. Aktien: -
>CONVATEC ADR Peer Group

 
02.06.25 - 11:36
RBC downgrades ConvaTec to “sector perform,” raises target to 320p (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
29.05.25 - 10:36
LONDON BROKER RATINGS: Kingfisher gets price targets raised (Alliance)
 
The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:----------FTSE 100----------Berenberg raises Diploma price target to 5,600 (5,200) pence - 'buy'----------UBS raises ConvaTec......
22.05.25 - 14:36
Convatec hails ′strong′ start to 2025 (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
22.05.25 - 10:42
ConvaTec gets revenue growth as remains on track for full-year targets (Alliance)
 
ConvaTec Group PLC on Thursday reported a rise in revenue during the first four months of 2025, and said it remained on track to deliver......
22.05.25 - 09:36
Convatec Reports YTD Organic Revenue Growth, Excl. InnovaMatrix, Of 6.7%; Updates FY25 Outlook (AFX)
 
LONDON (dpa-AFX) - Medical products and technologies company Convatec Group Plc (CTEC.L, CNVVY) reported strong year-to-date organic revenue growth of 6.7%, excluding InnovaMatrix, with broad-base......
14.04.25 - 09:36
ConvaTec lifts InnovaMatrix outlook after US LCD proposals postponed (Alliance)
 
ConvaTec Group PLC on Monday increased guidance for its wound dressing treatment InnovaMatrix after proposed legislative changes in the US were postponed. The London-based medical......
14.04.25 - 08:48
Convatec Lifts InnovaMatrix Sales Outlook After CMS Postpones LCDs In The U.S. (AFX)
 
LONDON (dpa-AFX) - Medical products and technologies company Convatec Group Plc (CTEC.L, CNVVY) Monday announced that it has raised its sales outlook of InnovaMatrix for fiscal 2025, after the U.S......
10.04.25 - 08:54
Observe Medical has entered into agreements in principle with major creditors for a 50% debt reduction (Cision)
 
Oslo, April 10[th], 2025 – Observe Medical ("the Company" or "Observe Medical") have reached agreements in principle with Convatec and Navamedic to reduce their debt position from in total NOK 82 million to NOK 41 million, with an adjusted payment plan for the remaining debt. Such debt reduction is conditional upon injection of new equity in the minimum amount of NOK 25 million. The Company has also been in constructive dialogue with existing shareholders and new investors who have indicated willingness to contribute equity in an amount of NOK 25 million, subject to debt reductions being...
18.03.25 - 20:42
Observe Medical ASA: Interim financial report for second half year 2024 (Cision)
 
Oslo, March 18, 2025 - Observe Medical ("the Company" or "Observe Medical") today releases its results and interim report for the second half and full year of 2024. Business update 2024 marked a pivotal transition toward the launch of UnoMeter Safeti Plus, historically the most revenue- and profit-generating product in the Convatec portfolio. Observe Medical is now focused on executing its strategy to reclaim UnoMeter's market position. In 2021, the UnoMeter product portfolio generated approximately NOK 220 million in annual revenue. With an estimated global market potential of NOK...
27.02.25 - 05:36
FTSE 100 opens higher; ConvaTec rallies while Aston Martin reverses - Market Report (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
27.02.25 - 01:24
FTSE 100 opens higher; ConvaTec rallies while Aston Martin reverses - Market Report (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.25 - 23:00
FTSE 100 opens higher; ConvaTec rallies while Aston Martin reverses - Market Report (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.25 - 12:06
FTSE 100 Advances; Convatec Rises On Strong Earnings (AFX)
 
BRUSSELS (dpa-AFX) - U.K. stocks are notably higher Wednesday morning, lifted by gains in mining and banking sectors. Slightly easing concerns over U.S. - Ukraine tensions after the two countries ......
26.02.25 - 10:18
Early market roundup: European stocks green as Convatec shines (Alliance)
 
Blue chip indices in London, Paris and Frankfurt opened higher on Wednesday morning, despite Hikma Pharmaceuticals falling on the FTSE 100. The FTSE 100 index......
26.02.25 - 10:12
ConvaTec posts higher annual profit and lifts dividend 3% for 2024 (Alliance)
 
Shares in ConvaTec Group PLC rose on Wednesday after the company reported a sharp increase in annual profit, supported by steady revenue growth. The medical......
13.02.25 - 10:42
LONDON BROKER RATINGS: UBS raises AstraZeneca to ′buy′ (Alliance)
 
The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:----------FTSE 100----------Goldman Sachs raises ConvaTec price target to 310 (300) pence - 'buy' ----------UBS......
06.01.25 - 15:06
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
 
LONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14. Kozmina will lead global human resources, serve on the Executive Leadership Team, and report to Vladimir Makatsaria, Chief Executive Officer. “Natalia has a deep background in the medtech and life sciences sectors and is a proven enterprise and executive leader in human resources management,” Makatsaria said. “I look forward to collaborating with Natalia to further strengthen our organizational culture and build a thriving environment at LivaNova.” Kozmina most recently served as Executive Vice President and CHRO of Convatec Group PLC (LSE: CTEC), a London-based global medical technologies company and constituent of the FTSE 100 Index. In this role, she developed and implemented transformative talent strategies to strengthen leadership capabilities across the bus...
19.11.24 - 12:19
Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months (Cision)
 
Oslo, 19 November, 2024 – Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company" or "Observe Medical") on 12 November 2024, in which it inter alia was stated that the Company is in dialogue with strategic and financial partners to evaluate options to further strengthen its working capital situation. The Company has today, through its subsidiary Observe Medical AS, reached an agreement with Convatec/Unomedical to defer all outstanding payments of consideration pursuant to the asset transfer agreement with Convatec/Unomedical for the...
14.11.24 - 21:30
Convatec expresses disappointment at InnovaMatrix Medicare exclusion (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
12.11.24 - 11:00
TOP NEWS: Bullish Convatec lifts guidance and predicts further growth (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!